SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.

Anavex Life Sciences Corporation

Anavex Life Sciences Corp

AVXL is trending as investors await a key decision from the EMA regarding its Alzheimer's drug, Blarcamesine, with an oral explanation scheduled. The community is actively discussing the implications of this oral explanation, analyzing potential outcomes and comparing Blarcamesine to existing treatments. Some traders express concerns about potential short attacks and are attempting to decipher the impact of an oral explanation.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is trending amid discussions surrounding a potential acquisition of Northern Data, with the community focused on the deal's implications for the platform's GPU and AI capabilities. Talk centers around Tether's growing investment in Rumble and its potential to boost the company's growth in the long term. Investors are also weighing upcoming earnings and the launch of Rumble Wallet.

Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health (OSCR) is trending due to uncertainty surrounding the extension of ACA subsidies and their potential impact on the company's future profitability. While some believe that the absence of subsidies could benefit OSCR's individual market focus, others are concerned about reduced affordability for consumers and the company's revenue. Community discussions also focus on technical analysis, potential catalysts, and speculation about a short squeeze.

Movano, Inc. is a health-focused technology company. The firm uses non-invasive technology to enable individuals and their healthcare partners to measure and manage their health conditions. It offers solutions through the app, the cloud, the wearable, and the sensor. The company was founded by Michael Aaron Leabman in January 2018 and is headquartered in Pleasanton, CA.

Movano Inc

Movano Inc. ($MOVE) is trending due to news of a Nasdaq listing extension, easing delisting concerns and attracting traders seeking quick gains. The community is actively discussing the stock's low float and potential for a short squeeze, with some eyeing sympathy plays in similar tickers. Speculation around future financial reports and AI integration from a potential merger are also fueling the conversation.

Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2. The company was founded by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye in 2011 and is headquartered in Boston, MA.

Galecto Inc

GLTO is trending due to a recent acquisition and a substantial funding round, igniting discussions around a potential short squeeze given the low float and high cost to borrow. Community members are actively debating entry and exit strategies amidst the stock's volatile price action and trading halts. The focus is on potential gains from a squeeze, while some caution against chasing the momentum.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

PGY is trending as investors react to recent earnings and future outlook, with community members debating whether the market is undervaluing the stock. Discussion centers on the company's profitability, growth potential, and the impact of short sellers, with some expressing concerns about market manipulation. Bullish investors anticipate a significant price increase, while bears cite concerns about consumer credit and broader economic conditions.

Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs target the development of carbohydrate molecules which offers alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

Galectin Therapeutics Inc

GALT is trending with growing anticipation for the AASLD Liver Meeting in November, where new data is expected to be revealed, fueling speculation around potential partnerships or a buyout before the end of the year. Community members are actively discussing the value of Belapectin, especially its potential synergy with GLP-1 drugs, and a possible short squeeze due to high short interest. Some investors speculate on a buyout price in the double digits.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TGTX is trending as investors debate the cause of recent price declines despite seemingly positive financial results, with community members pointing to competition from Roche and potential profit-taking as factors. Discussion revolves around whether the company will be acquired, if a buyback will occur, and the impact of insider share transfers. Bullish arguments center on Briumvi's market position and potential, while bears cite chart patterns and macro conditions.

Papa John's International, Inc. engages in the operation and franchise of pizza delivery and carryout restaurants. It operates through the following segments: Domestic Company-owned Restaurants, North America Franchising, North America Commissaries, International Operations, and All Others. The Domestic Company-Owned Restaurants segment consists of retail sales of pizza and side items, breadsticks, cheese sticks, chicken poppers and wings, dessert items, and canned and bottled beverages. The North America Franchising segment involves the offering of sales and support activities, development rights, and collection of royalties from franchisees located in the United States and Canada. The North America Commissaries segment includes the eleven full-service regional dough production and distribution and quality control centers. The International Operations segment represents all restaurant operations outside of the United States and Canada. The All Others segment focuses on franchise contributions to marketing funds and sale, company-owned and franchised restaurants, information systems and related services used in restaurant operations, point-of-sale system, online and other technology-based ordering platforms, printing, and promotional items. The company was founded by John H. Schnatter in 1984 and is headquartered in Louisville, KY.

Papa John`s International, Inc.

$PZZA is trending due to private equity firm Apollo withdrawing its bid to acquire the company, causing a significant stock drop. The community is discussing the potential reasons for the deal falling through, as well as its impact, with some seeing it as a buying opportunity. Many traders are also pointing to competitor $YUM as a more attractive play.

MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.

Mannkind Corp

Mannkind's stock is trending downwards following news that its Phase 3 trial for nebulized clofazimine failed to demonstrate efficacy, leading the company to discontinue the trial and shift focus to a dry powder version. The community is expressing disappointment with the company's leadership and questioning the future of the stock, with some speculating about a potential acquisition. Investors are discussing the implications for future earnings and expressing concern about the company's pipeline and strategic decisions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$PYPL  
**Dates to Remember**  
Ex-Dividend Date: November 19, 2025   
Why is this important?  
The ex-dividend date is the cutoff for determining if a shareholder is eligible to receive a company&#39;s next dividend payment. To receive the dividend, you must own the stock before the ex-dividend date. If you buy the stock on or after the ex-dividend date, you will not receive the dividend.   
Record Date: November 19, 2025  
Payment Date: December 10, 2025  
Dividend Amount: $0.14 per share  
It&#39;s only a matter of time :)

SuperMicroComputer

StockTwits Web

PayPal Holdings Inc

  
**Dates to Remember**  
Ex-Dividend Date: November 19, 2025   
Why is this important?  
The ex-dividend date is the cutoff for determining if a shareholder is eligible to receive a company's next dividend payment. To receive the dividend, you must own the stock before the ex-dividend date. If you buy the stock on or after the ex-dividend date, you will not receive the dividend.   
Record Date: November 19, 2025  
Payment Date: December 10, 2025  
Dividend Amount: $0.14 per share  
It's only a matter of time :)